Jacobiopharma
3 known investors
Jacobio Pharmaceuticals is a biotech company that develops first-in-class oncology drugs using its allosteric drug discovery platform and iADC platform, targeting difficult-to-drug targets across validated tumor signaling pathways. It focuses on combination therapies for cancer treatment and pursues out-licensing partnerships for global markets.
BiotechDeep TechHealthtech
Investors · 3
Frequently asked questions
- What does Jacobiopharma do?
- Jacobio Pharmaceuticals is a biotech company that develops first-in-class oncology drugs using its allosteric drug discovery platform and iADC platform, targeting difficult-to-drug targets across validated tumor signaling pathways. It focuses on combination therapies for cancer treatment and pursues out-licensing partnerships for global markets.
- Who are Jacobiopharma's investors?
- Jacobiopharma's investors include LAV, Lilly Asia Ventures, Qiming Venture Partners.